Maison Clio Blue SA

MLCLI.PA plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MLCLI.PA stands at 7.9M. In comparison, MC.PA has a market cap of 229B. Regarding current trading prices, MLCLI.PA is priced at €2.06, while MC.PA trades at €461.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MLCLI.PA currently has a P/E ratio of N/A, whereas MC.PA's P/E ratio is 20.97. In terms of profitability, MLCLI.PA's ROE is +0.00%, compared to MC.PA's ROE of +0.19%. Regarding short-term risk, MLCLI.PA is more volatile compared to MC.PA. This indicates potentially higher risk in terms of short-term price fluctuations for MLCLI.PA.Check MC.PA's competition here

MLCLI.PA plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MLCLI.PA stands at 7.9M. In comparison, RMS.PA has a market cap of 217.9B. Regarding current trading prices, MLCLI.PA is priced at €2.06, while RMS.PA trades at €2,078.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MLCLI.PA currently has a P/E ratio of N/A, whereas RMS.PA's P/E ratio is 48.79. In terms of profitability, MLCLI.PA's ROE is +0.00%, compared to RMS.PA's ROE of +0.28%. Regarding short-term risk, MLCLI.PA is more volatile compared to RMS.PA. This indicates potentially higher risk in terms of short-term price fluctuations for MLCLI.PA.Check RMS.PA's competition here

MLCLI.PA plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MLCLI.PA stands at 7.9M. In comparison, CDI.PA has a market cap of 79.5B. Regarding current trading prices, MLCLI.PA is priced at €2.06, while CDI.PA trades at €440.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MLCLI.PA currently has a P/E ratio of N/A, whereas CDI.PA's P/E ratio is 17.43. In terms of profitability, MLCLI.PA's ROE is +0.00%, compared to CDI.PA's ROE of +0.22%. Regarding short-term risk, MLCLI.PA is more volatile compared to CDI.PA. This indicates potentially higher risk in terms of short-term price fluctuations for MLCLI.PA.Check CDI.PA's competition here

MLCLI.PA plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MLCLI.PA stands at 7.9M. In comparison, KER.PA has a market cap of 26.5B. Regarding current trading prices, MLCLI.PA is priced at €2.06, while KER.PA trades at €216.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MLCLI.PA currently has a P/E ratio of N/A, whereas KER.PA's P/E ratio is 36.39. In terms of profitability, MLCLI.PA's ROE is +0.00%, compared to KER.PA's ROE of +0.08%. Regarding short-term risk, MLCLI.PA is more volatile compared to KER.PA. This indicates potentially higher risk in terms of short-term price fluctuations for MLCLI.PA.Check KER.PA's competition here

MLCLI.PA plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MLCLI.PA stands at 7.9M. In comparison, DPT.PA has a market cap of 93.6M. Regarding current trading prices, MLCLI.PA is priced at €2.06, while DPT.PA trades at €0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MLCLI.PA currently has a P/E ratio of N/A, whereas DPT.PA's P/E ratio is -9.92. In terms of profitability, MLCLI.PA's ROE is +0.00%, compared to DPT.PA's ROE of -0.04%. Regarding short-term risk, MLCLI.PA is more volatile compared to DPT.PA. This indicates potentially higher risk in terms of short-term price fluctuations for MLCLI.PA.Check DPT.PA's competition here